Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences
Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced its participation in two upcoming investor conferences. The Jefferies Virtual Gene Therapy / Editing Summit will take place on October 1st at 12:00 PM ET, followed by the Chardan Genetic Medicines Conference on October 5th at 8:00 AM ET. Both presentations will be webcast live and accessible via the Sangamo website's Investors and Media section. The company's focus is on developing genomic medicines, including gene therapy and genome editing.
- None.
- None.
BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences:
-
Jefferies Virtual Gene Therapy / Editing Summit
Thursday, October 1st at 12:00 pm Eastern Time
-
Chardan Genetic Medicines Conference
Monday, October 5th at 8:00 a.m. Eastern Time
Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and genome regulation. For more information about Sangamo, visit www.sangamo.com.
